ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Savara Inc

Savara Inc (SVRA)

6,03
-0,26
(-4,13%)
Geschlossen 11 Juli 10:00PM
6,03
0,00
(0,00%)
Nach Börsenschluss: 1:55AM

Savara Inc (SVRA) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
6,03
( -4,13% )
Gebot
5,75
Fragen
6,50
Volumen
1.720.446
Durchschnittliches Volumen (3 Mio.)
US$ 1.569.630
Finanzvolumen
US$ 10.400.979
5,93 Tagesbereich 6,29
2,24 52-Wochen-Bereich 7,005
Marktkapitalisierung
Unternehmenswert
1,403B
Handelsende
6,29
Handelsbeginn
6,29
Letzte Trade
1
@
6.03
Letzter Handelszeitpunkt
VWAP
6,0455
Erlöse (LTM)
-
Nettogewinn (LTM)
-129,48M
Ausgegebene Aktien
253.600.145
Streubesitz (%)
51,32%
Institutioneller Besitz (%)
84,00%
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-11,13
Kurs-Umsatz-Verhältnis (KUV)
-
Gewinn pro Aktie (EPS)
-0,56
Beta
0,24

Über Savara Inc

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company’s lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune... Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company’s lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. was founded in 2007 and is headquartered in Yardley, Pennsylvania. Mehr anzeigen

Sektor
Health Care
Branche
-
Hauptsitz
Yardley, United States
Gegründet
2026
Savara Inc is listed in the Health Care sector of the NASDAQ with ticker SVRA. The last closing price for Savara was US$6,29. Over the last year, Savara shares have traded in a share price range of US$ 2,24 to US$ 7,005.

Savara currently has 253.600.145 shares in issue. The market capitalisation of Savara is US$1,53 billion. Savara has a price to earnings ratio (PE ratio) of -11.13.

SVRA Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.2-3.210272873196.236.4756.0218174126.27306149CS
40.7614.42125237195.276.4755.201421403645.87258898CS
120.244.145077720215.796.4754.69516347195.4482412CS
260.233.965517241385.86.494.69515270715.50280669CS
523.65153.3613445382.387.0052.2416920765.04001177CS
1562.9193.26923076923.127.0051.8912929524.24567785CS
2604.51296.7105263161.527.0051.028796223.95632573CS

SVRA - Frequently Asked Questions (FAQ)

What is the current Savara Inc share price?
The current share price of Savara Inc is US$ 6,03
How many Savara Inc shares are in issue?
Savara Inc has 253.600.145 shares in issue
What is the market cap of Savara Inc?
The market capitalisation of Savara Inc is USD 1,53B
What is the 1 year trading range for Savara Inc share price?
Savara Inc has traded in the range of US$ 2,24 to US$ 7,005 during the past year
What is the PE ratio of Savara Inc?
The price to earnings ratio of Savara Inc is -11,13
What is the registered address of Savara Inc?
The registered address for Savara Inc is The Tannery, Yardley, Pennsylvania, 19067
What is the Savara Inc website address?
The website address for Savara Inc is www.savarapharma.com

SVRA Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen